Martinsried, Germany

Roland Koestler

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 5.2

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Roland Koestler

Introduction

Roland Koestler is a prominent inventor based in Martinsried, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of kinase modulators. With a total of four patents to his name, Koestler's work focuses on addressing various diseases through innovative compounds.

Latest Patents

Koestler's latest patents include the development of 1,4-dihydrobenzo[d]pyrazolo[3,4-f][1,3]diazepine derivatives and related compounds. These compounds serve as modulators for LRRK2, NUAK1, and/or TYK2 kinases, which are crucial in the treatment of autoimmune diseases. The invention details compounds capable of modulating these kinases, which can be beneficial in treating a wide range of conditions, including inflammatory diseases, neurological disorders, and cancer. An exemplary compound from his research is 5-(2,6-difluorophenyl)-8-methoxy-1,4-dihydrobenzo[d]pyrazolo[3,4-f][1,3]diazepine.

Career Highlights

Koestler is currently associated with Origenis GmbH, where he continues to push the boundaries of pharmaceutical innovation. His work has been instrumental in the synthesis and characterization of compounds that have the potential to revolutionize treatment options for various diseases.

Collaborations

Throughout his career, Koestler has collaborated with notable colleagues, including Michael Almstetter and Michael Thormann. These partnerships have enhanced the research and development of his innovative compounds.

Conclusion

Roland Koestler's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new treatments that can significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…